|
|
 |
|
Viewing report
|
|
|
|
Key Opinion Leader Mapping. Breast Cancer: USA Landscape Analysis. Special Focus on KOLs of Tomorrow.
FAS Research, May 2008, Pages: 68
Pharma’s appetite for KOLs is growing. This report provides the names and affiliated institutions of the most influential Key Opinion Leaders in the US Breast Cancer Market and shows how they are connected and influence each other. We analyzed who will be the KOLs of tomorrow and whose influence is on decline.
Scope
- Overview of the current and future Key Opinion Leader Landscape (M.D.s as well as hospitals) in the US breast cancer market.
- Actionable Segmentation of Key Opinion Leaders for particular roles like: Who are the best for peer conversion, who are the best for market entry and who are the best for advocacy; as well as particular potential tasks, such as advisory board members, consultants, investigators, education, etc.
- Identification of KOLs of Tomorrow (Rising and Sinking Stars) based on dynamic network analysis.
- 28 Detailed as well as four 10,000 foot Strategy Maps (Network Visualizations) of doctor-to-doctor network relations and the clusters they form around proposed or opposed therapies.
Reasons to Purchase Report
- Invest into the right KOLs for advisory boards, expert speakers, consulting engagements, investigation sites etc.
- Shorten your lead time and precisely deploy limited resources for maximum Key Account Management impact.
- Foster trust with influencers and KOLs of tomorrow. They are more accessible, more open to innovation and require less investment.
- Evidence validates Experience. While a large part of the report will validate your market experience, our sophisticated algorithms and understanding of the market will provide an objective edge on the covert market dynamics. Information you can’t afford, to not have.
- Understand and cultivate doctor’s chains of influence (direct and indirect peer pressure). It will help you to optimize the impact of business intelligence and product advocacy. And it will help you to launch successfully and quickly build a critical mass of product supporters.
- As a complimentary add on to the report we offer two hours of personal consulting on how to best put this knowledge into action and increase the ROI on your KOL Management.
Customers who bought this item also bought
Key Opinion Leader Mapping. Breast Cancer: USA Landscape Analysis. Special Focus on KOLs of Tomorrow.
China: Tomorrow�s leader in electronics
Drugs of Tomorrow: Cancer Overview
Value Creation: Building Tomorrows Finance Function
Drugs of Tomorrow 2001: Cancer Overview
Drugs of Tomorrow 2001: Diabetes
Drugs of Tomorrow 2001: Lung Cancer
Drugs of Tomorrow 2002: Colorectal Cancer
|
|
|
|
